NCT03630276

Brief Summary

Evaluation of neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP as markers of severity of Pre-eclampsia

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
111

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 10, 2018

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 14, 2018

Completed
Last Updated

August 14, 2018

Status Verified

August 1, 2018

Enrollment Period

9 days

First QC Date

August 10, 2018

Last Update Submit

August 10, 2018

Conditions

Pre-Eclampsia

Outcome Measures

Primary Outcomes (1)

  • PREECLAMPSIA

    6months

Study Arms (3)

Neutrophil/lymphocyte ratio

OTHER
Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP

Platelet/lymphocyte ratio

OTHER
Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP

CRP

OTHER
Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP

Interventions

Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRPDIAGNOSTIC_TEST

Lab

CRPNeutrophil/lymphocyte ratioPlatelet/lymphocyte ratio

Eligibility Criteria

Age25 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \- PREECLAMPSIA from 25\_45years

You may not qualify if:

  • chronic diseases Primary hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaza

Alexandria, Alex, 12345, Egypt

RECRUITING

MeSH Terms

Conditions

Pre-Eclampsia

Interventions

Platelet Count

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Blood Cell CountCell CountCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHematologic TestsPlatelet Function TestsInvestigative TechniquesCell Physiological PhenomenaBlood Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Shaza Mohamed Elreweny

Study Record Dates

First Submitted

August 10, 2018

First Posted

August 14, 2018

Study Start

August 1, 2018

Primary Completion

August 10, 2018

Study Completion

August 10, 2018

Last Updated

August 14, 2018

Record last verified: 2018-08

Locations

EG(1)